J&J Targeted Docs To Push Fentanyl Patch, Okla. Judge Hears
A regional sales director for Johnson & Johnson subsidiary Janssen called the company's self-described efforts to "target" and "influence" doctors into increasing prescriptions for its Duragesic fentanyl patch as the mere...To view the full article, register now.
Already a subscriber? Click here to view full article